BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20260820T215248Z
UID:bdb8b840-3da4-4beb-8ff1-abb54880cc43
DTSTART:20161114T090000Z
DTEND:20161116T000000Z
DESCRIPTION:Cambridge Healthtech Institute’s inaugural conference on Use 
 of CRISPR &amp\; RNAi for Drug Discovery will cover the latest in the use 
 of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9
 -based gene editing and RNA interference (RNAi) for use in drug discovery 
 and for developing novel drug therapies. It will bring together experts fr
 om all aspects of basic science and clinical research to talk about how an
 d where gene editing and RNAi can be best applied. The talks will discuss 
 how the CRISPR/Cas system compares to RNAi and if they can be used in a co
 mplementary fashion. Scientists and clinicians will share best practices o
 n everything from assay design to data analysis when conducting low and hi
 gh throughput screens and generating cellular models\, both in vitro and i
 n vivo\, using CRISPR/Cas9\, siRNA (small interfering RNA)\, and shRNA (sh
 ort hairpin RNA) for functional screening\, pathway analysis\, target disc
 overy\, disease modeling\, and for enabling cell and viral therapies.
LOCATION:Sheraton Lisboa Hotel
SUMMARY:Use of CRISPR&RNAi For Drug Discovery
URL;VALUE=URI:http://www.worldpreclinicaleurope.com/CRISPR-and-RNAi-for-Dru
 g-Discovery/
END:VEVENT
END:VCALENDAR